BioCatalystWatch
CAMPWorkspace / CAMP / OverviewCompany library
Camp4 Therapeutics Corp logo

Camp4 Therapeutics Corp

Camp4 Therapeutics Corp (CAMP)

Website

Price
Market cap
Next catalystExpected Q4 2026CMP-002 — ASCEND Phase 1/2 · Trial initiationSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

CMP-002

SYNGAP1 regRNA × SYNGAP1

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

CMP-002

SYNGAP1 regRNA × SYNGAP1

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

History / paused

CPS1 regRNA × CPS1

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

CAMP PR & News

PR & News

CAMP SEC archive